The landscape of dementia prognosis has developed substantially with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of signs or symptoms emerge. Whilst these technological innovations characterize impressive progress in being familiar with neurodegenerative https://samuell430kve0.blogoxo.com/profile